INTRODUCTION
============

Oocyte maturation and oocyte quality are important parameters in successful reproductive results of the assisted reproduction technologies (ART). Mitochondria are the most abundant organelles in the cytoplasmic oocyte \[[@b1-bjmg-18-01-39]\]. They are necessary for adenosine triphosphate (ATP) generation through oxidativephosphorylation (OXPHOS), unlike any other process of the cell, and depend highly on the expression of proteins encoded by the mitochondrial and nuclear encoded gene \[[@b1-bjmg-18-01-39],[@b2-bjmg-18-01-39]\]. Mitochondria are inherited exclusively from the mother \[[@b3-bjmg-18-01-39]\]. Indeed, mitochondrial function is associated with mitochondrial DNA (mtDNA) \[[@b4-bjmg-18-01-39],[@b5-bjmg-18-01-39]\]. The mitochondrial genome encodes essential proteins, which are crucial for the generation of ATP. These proteins are transcribed and translated in the mitochondrial matrix \[[@b6-bjmg-18-01-39]\]. Human oocyte mitochondrion has only a single copy of the genome, which is representative of the mitochondrial number. However, it has been clearly documented that mtDNA number is expanded during oocyte growth \[[@b7-bjmg-18-01-39]\].

Mitochondrial biogenesis is managed independently from the nuclear genome and depend on regulatory coordination between the nuclear and mitochondrial genomes \[[@b8-bjmg-18-01-39]\]. However, little is known about the regulation of mitochondrial gene expression, compared with nuclear genes \[[@b8-bjmg-18-01-39]\]. Regulatory coordination of the nuclear and mitochondrial genes are important in cell survival and energy homeostasis \[[@b9-bjmg-18-01-39]\]. Two products of these genes, *NRF1* and *TFAM*, are well-known essential ubiquitous factors for the mtDNA replication and expression \[[@b10-bjmg-18-01-39]\]. The *NRF1* gene contributes in regulating the expression of nuclear encoded components of the mitochondrial respiratory chain \[[@b11-bjmg-18-01-39]\]. The human *TFAM* is a 25 kD protein with nuclear-encoded high-mobility group (HMG) box protein, which plays an important role through sequence binding to the heavy strand promoter (HSP) and light strand promoter (LSP) sites in the D-loop of human mtDNA, a control region that regulates mtDNA transcription and replication \[[@b12-bjmg-18-01-39]--[@b14-bjmg-18-01-39]\]. The *TFAM* gene has various functions, including packaging mtDNA into a nucleoid-like complex and maintaining and repairing mtDNA molecules \[[@b15-bjmg-18-01-39],[@b16-bjmg-18-01-39]\]. *NRF1* has also been shown to be linked to the promoters of the *TFAM* gene \[[@b17-bjmg-18-01-39]\]. Their important roles have been demonstrated by transgenic experiments, showing that depletion of mtDNA in *TFAM* and *NRF1* homozygous knockout mice resulted in the animals' deaths \[[@b18-bjmg-18-01-39],[@b19-bjmg-18-01-39]\]. Another factor, *MT-CO1*, is a terminal component and one of the three genes of mitochondrial respiratory chain, encoded by the mtDNA \[[@b19-bjmg-18-01-39]--[@b21-bjmg-18-01-39]\]. Transcription levels of the *MT-CO1* gene may possibly be an indirect indicator of the mtDNA metabolic activity.

Active transcription of the mitochondrial genome has been demonstrated to initiate at various developmental stages, depending on the species \[[@b22-bjmg-18-01-39]\]. Reports from many studies suggested that gene-specific transcription factors directly affect gene transcription in mitochondria \[[@b23-bjmg-18-01-39]\]. However, relationship between the expression levels of nuclear and mitochondrial encoded genes during human oocyte maturation is not well understood. The aim of the current study was to quantify the relationship between relative expression levels of *NRF1* and *TFAM*, and the *MT-CO1* genes in single human oocytes at various stages of the human oocyte maturation from germinal vesicle (GV) stage to metaphase II (MII) stage.

MATERIALS AND METHODS
=====================

Sample Collection
-----------------

Oocytes in various stages of human oocyte maturation were obtained from nine normal women (20--35 years old), undergoing intracytoplasmic sperm injection (ICSI) treatment because of male factor infertility. There was no evidence of ovarian pathology for any of the patients donating oocytes. Examination proceeded according to the following criteria: ***1)*** medical history, clinical examination and common hormonal tests; ***2)*** Rotterdam criteria to ensure polycystic ovary syndrome; ***3)*** diseases related to the endocrine system, such as hyperprolactinemia, thyroid dysfunction; ***4)*** possible surgical history of the reproductive system; ***5)*** normal ovulatory period (25--35 days); ***6)*** body mass index (BMI) between 18.3--22.2 kg/m^2^; ***7)*** day 3 basal ultrasonography and hormone profile with follicle-stimulating hormone (FSH) \<10.0 mIU/mL, estradiol \<40.0 pg/mL and antral follicle count (AFC) \>6; and ***8)*** no history of smoking.

Treatment and Donation
----------------------

Informed consent were obtained from the patients at the Infertility and Reproductive Health Research Center (IRHRC) at Taleghani Hospital of Shahid Beheshti University of Medical Sciences and Sarem Women's Hospital, Tehran, Iran. The study protocol was approved by the Ethical Committee of Shahid Beheshti University of Medical Sciences, Tehran, Iran. All nine patients were treated according to the agonist protocol. The gonadotropin-releasing hormone (GnRH) agonist was begun in mid-luteal phase of the previous cycle (day 21), as determined by serum E2 and P concentrations. Stimulation of the follicular growth, performed by FSH recombination, was started after sufficient down-regulation.

This continued by daily injections according to individual endocrine and ovarian ultrasonic responses until at least one 18 mm diameter follicle showed. Ovulation was induced by human chorionic gonadotropin (HCG). Thirty-six hours later, vaginal puncture was performed under ultrasound-guided *in vitro* fertilization (IVF) and ICSI protocols using transvaginal probes for follow-up of the cumulus-oocyte complex (COC). First, mechanical procedures used to remove cumulus granulose cells by intermittent pipetting and then followed by enzymatic hyaluronidase treatment. Oocytes were subsequently washed in culture media (global media) before use. Collected oocytes were studied for nuclear maturity under a stereo microscope (Olympus, Tokyo, Japan). Morphological characteristics of the collected oocytes were classified into three categories based on the nuclear condition: ***1)*** mature oocytes (MII) with first polar body (*n* = 8); ***2)*** immature oocytes GV (*n =* 10); and ***3)*** immature oocytes \[metaphase I (MI)\] without original polar body (*n* = 9).

Sample Processing for Gene Expression
-------------------------------------

Oocytes were processed using Ambion Single Cell-to-CT® Kit (Life Technologies, Foster City, CA, USA) according to the manufacturer's protocol. Sibling oocytes were rapidly transferred to sterile RNase-free microtubes to minimize any changes in gene expression. Then, oocytes were transferred to lysis solution containing DNase I. The enzyme was inactivated using stop solution following 5 min. of incubation at room temperature and DNA digestion. Then, Single Cell VILO® RT Mix and Single Cell SuperScript® RT (Life Technologies, Carlsbad City, CA, USA) were added to each sample reaction. Reverse transcription-PCR (RT-PCR), was performed using 15.5 μL sample volume per reaction. After completing RT-PCR, PreAmp® reaction mixtures were prepared by adding 0.2 × pooled TaqMan® Gene expression assay to Single Cell PreAmp® Mix (Life Technologies) for each gene. Then, cDNA of each gene was specifically amplified through the following thermal cycling condition: 95 °C for 10 min. and then 17 cycles that included 15 seconds at 95 °C and 4 min. at 60 °C and a final 10 min. heat at 99 °C.

Gene Expression Analysis
------------------------

Quantitative RT-PCR was used to quantify mRNA transcript levels of *TFAM*, *MT-CO1* and *NRF1* genes using hypoxanthine phosphoribosyltransferase 1 (HPRT1) mRNA transcripts as endogenous reference. Relative mRNA expression levels of the studied genes were quantified using TaqMan® qRT-PCR analysis (Applied Biosystems, Foster City, CA, USA) in 48-well plates. Relative gene expression was calculated using the 2-ΔΔCT formula. The Ct value of each transcript was calculated *via* TaqMan® (Applied Biosystems) gene expression assay for transcripts.

Designing Primers and Probes
----------------------------

The specifications of the forward and reverse primers and Taq-Man® (Applied Biosystems) probes are listed in [Table 1](#t1-bjmg-18-01-39){ref-type="table"}.

Statistical Analysis
--------------------

Analysis of variance (ANOVA) with the post-hoc Tukey test and the Statistical Package for the Social Sciences (SPSS Inc., Chicago, IL, USA) software, version 16.0, were used to determine differences between the mean values.

RESULTS
=======

For the first time, the present study showed detailed temporal expression of mRNAs associated to mitochondria during human oocyte maturation. Results showed that the mean expression levels of *TFAM* and *NRF1* were relatively low as well as the *MT-CO1* genes in GV-stage oocytes. No significant difference was seen between the expression levels of all studied genes (*p* = 0.62) ([Figure 1A](#f1-bjmg-18-01-39){ref-type="fig"}). Significant differences were detected in the mean expression levels of *TFAM* and *NRF1*, and the *MT-CO1* genes when the oocyte maturation began and transited to the MI stage (*p =* 0.03) ([Figure 1B](#f1-bjmg-18-01-39){ref-type="fig"}). At the MII stage, significant differences were reported between the expression levels of *TFAM* and *NRF1*, and the *MT-CO1* (*p* = 0.002) genes ([Figure 1C](#f1-bjmg-18-01-39){ref-type="fig"}). Furthermore, significant differences were seen between the expression levels of *NRF1* and *TFAM*, and the *MT-CO1* genes at the MI and MII stages ([Figure 2](#f2-bjmg-18-01-39){ref-type="fig"}).

DISCUSSION
==========

Oocytes require a large supply of ATP for maturation to support critical processes such as spindle formation, chromatid separation and cell division after fertilization \[[@b24-bjmg-18-01-39]--[@b26-bjmg-18-01-39]\]. Mitochondrial number increases during oocyte maturation at a direct ratio to increase copy number of mtDNA \[[@b27-bjmg-18-01-39]--[@b29-bjmg-18-01-39]\]. For the first time, this study identified the relationship between the relative expression levels of nuclear and mitochondrial encoded genes at various stages of human oocyte maturation using single-cell qRT-PCR. This method evaluated the relative gene expression levels in single oocytes without isolating RNA. In the present study, relationship between the relative expression levels of *TFAM* and *NRF1*, and the *MT-CO1* genes was significant in MI and MII stage oocytes. Therefore, it can be concluded that nuclear-mitochondrial relationships occur by active transcriptions during human oocyte maturation.

No relationship was observed between mRNA expression levels of nuclear and mitochondrial encoded genes in immature oocytes (GV stage). However, contrary to the findings of the current study in GV-stage oocytes, a high expression level of *TFAM* was observed by increasing the relative expression level of the *MT-CO1* gene. In MII-stage oocytes, a significant difference was detected between the relative mRNA levels of *TFAM* and *NRF1*, and the *MT-CO1* genes. This can be explained by the response of regulation mechanism to changes in energy demand associated with a large number of mtDNA copies at this stage. Previous studies have shown that a relative expression level of *TFAM* results in further direct mtDNA replication \[[@b18-bjmg-18-01-39],[@b30-bjmg-18-01-39], [@b31-bjmg-18-01-39]\]. Furthermore, studies have reported that *NRF1* transactivates the promoters of a number of mitochondrial-linked genes such as *TFAM*, including genes that encode respiratory chain subunits \[[@b32-bjmg-18-01-39]\].

Results showed a high expression level of the nuclear encoded *TFAM* gene with important mitochondrial encoded *MT-CO1* gene upregulation in MI- and MII-stage oocytes, which could confirm the activation of mtDNA heavy strand promoter by *TFAM*, causing the relative expression of mRNA encoding mitochondrial proteins such as cytochrome oxidase subunit 1 (COX1). This causes further differentiation of mitochondria in MI and MII stages \[[@b5-bjmg-18-01-39],[@b33-bjmg-18-01-39]--[@b35-bjmg-18-01-39]\]. It is commonly accepted that *NRF1*, *TFAM* and *MT-CO1* genes serve as markers of mitochondrial differentiation \[[@b36-bjmg-18-01-39]--[@b38-bjmg-18-01-39]\]. Moreover, it seems that the increased expression of *NRF1* positively affects *TFAM* binding to regulatory regions of the MT-CO1 promoter; therefore, *TFAM* is well known as a main mitochondrial transcription factor, regulating mtDNA copy number and mtDNA transcription activity \[[@b39-bjmg-18-01-39]\].

However, a relationship has been observed between the upregulated gene expression of *NRF1* and *TFAM*, and the *MT-CO1* in MII-stage oocytes, compared to GV-stage human oocytes. Similarly, previous studies have reported that *TFAM* reduction resulted in decreased mitochondrial COX1 expression to lower than 30.0% of the normal expression level and caused embryonic lethality \[[@b25-bjmg-18-01-39]\]. Another study has revealed that delayed expression of mtDNA replication factors result in delayed mtDNA replication and reduced development of oocyte competence \[[@b27-bjmg-18-01-39]\].Other studies have also demonstrated that the homozygous knockout embryos of *TFAM* (TFAM \[−/−\]) die due to deficiencies in impaired respiratory chain \[[@b17-bjmg-18-01-39],[@b23-bjmg-18-01-39]\]. Therefore, it may be concluded that increase in transcription levels in oocyte mitochondria results in increase in mtDNA due to demanded ATP levels during human oocyte maturation, which are important steps in oocyte maturation \[[@b40-bjmg-18-01-39]--[@b42-bjmg-18-01-39]\]. In conclusion, the present study has supported the fact that the relationship between the relative expression level of nuclear encoded genes (*TFAM*, *NRF1*) and the mitochondrial-encoded gene (*MT-CO1*) is associated with human oocyte maturation and subsequently, oocyte quality. However, further investigations with appropriate methodology are required to better understand unknown aspects of this relationship.
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![Relationship between mitochondrial related mRNA expression levels of *TFAM*, *NRF1* and *MTCO1* genes at GV, MI, MII stages of human oocyte maturation (A, B, C, respectively). A: *p* = 0.62; B: *p* = 0.03; C: *p* = 0.002. Superscript asterisk (\*) shows statically significant differences (\<0.05). Data are presented as means ± standard deviation (SD).](bjmg-18-01-39f1){#f1-bjmg-18-01-39}

![Relationship between the mean relative expression levels of nuclear encoded (*TFAM*, *NRF1*) and the mitochondrial encoded (*MT-CO1*) genes at various stages of the human oocyte maturation. GV: *p* = 0.58; MI: *p* = 0.23; MII: *p* = 0.012.\
Superscript asterisk (\*) shows statically significant differences (\<0.05). Data are presented as means ± standard deviation (SD).](bjmg-18-01-39f2){#f2-bjmg-18-01-39}

###### 

Primers and TaqMan® (Applied Biosystems) probe sequences used in quantitative real-time polymerase chain reaction.

  Gene       Forward Primer Sequences (5′\>3′)                 Reverse Primer Sequences (5′\>3′)
  ---------- ------------------------------------------------- -------------------------------------
  *NRF1*     GGC ACT GTC TCA CTT ATC CAG GT T                  CAG CCA CGG CAG AAT AAT TCA
  *TFAM*     AAG ATT CCA AGA AGC TAA GGG TGA                   CAG AGT CAG ACA GAT TTT TTC CAG TTT
  *MT-CO1*   GAG CTG CTG TTC GGT GTC C                         TGC CAG TGG TAG AGA TGG TTG
  *HPRT1*    TGG ACT AAT TAT GGA CAG GAC TGA AC                GCA CAC AGA GGG CTA CAA TGTG
  Gene       Probe Sequences (5′\>3′)                          
  *NRF1*     FAM-ACC ACG GTC ACC GTT GCC CAA-BHQ1              
  *TFAM*     FAM-CAC CGC AGG AAA AGC TGA AGA CTG TAA AG-BHQ1   
  *MT-CO1*   FAM-CAA TAC CGC AAC CGC ATT GCC AT-BHQ1           
  *HPRT1*    FAM-CTC CCA TCT CCT TCA TCA CAT CTC GAG C-BHQ1    
